High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis
The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Do women with polycystic ovary syndrome (PCOS) have an increased prevalence of moderate and severe depressive and anxiety symptoms compared with control women, and do these symptoms correlate with age, BMI, testosterone, hirsutism or insulin resistance (IR)? SUMMARY ANSWER: Women with PCOS have significantly increased odds of moderate and severe depressive and anxiety symptoms, independent of obesity, and the symptoms are weakly associated with age, BMI, elevated testosterone, hirsutism and IR. WHAT IS KNOWN ALREADY: Previous studies have reported that women with PCOS have an increased prevalence of mild depressive and anxiety symptoms or an increase in mean depression and anxiety scores, although these scores are usually within the normal range. Thus, it is therefore not clear whether these findings are clinically significant. The prevalence of moderate and severe depressive and anxiety symptoms, which require follow-up and would benefit from treatment, is not known in this population. STUDY DESIGN, SIZE, DURATION: A comprehensive systematic review (SR) was performed up to January 2016 and included 30 cross-sectional studies, representing 3050 subjects with PCOS and 3858 controls, from 10 different countries. The meta-analysis (MA) on depressive symptoms included 18 studies and the MA on anxiety symptoms included 9 studies. A separate SR identified 15 studies for the meta-regression examining the associations with PCOS-related symptoms or comorbidities. PARTICIPANTS/MATERIALS, SETTING, METHODS: All studies included adult women with PCOS, defined by the National Institutes of Health or Rotterdam criteria, and a control group without PCOS. Ovid, Embase, PsychInfo and Cochrane were searched up to January 2016. Included studies used a validated screening tool to compare the prevalence or mean scores of depressive and/or anxiety symptoms. Random effects MA was used to estimate the pooled odds ratio (OR) of depressive and anxiety symptoms. Sensitivity analyses of methodological characteristics and a meta-regression of the pooled standardized mean difference (SMD) to evaluate PCOS-related clinical and laboratory associations were performed. MAIN RESULTS AND THE ROLE OF CHANCE: Women with PCOS had increased odds of any depressive symptoms (OR: 3.78; 95% CI: 3.03-4.72; 18 studies) and of moderate/severe depressive symptoms (OR: 4.18; 95% CI: 2.68-6.52; 11 studies). Women with PCOS had increased odds of any anxiety symptoms (OR: 5.62; 95% CI: 3.22-9.80, nine studies) and of moderate/severe anxiety symptoms (OR: 6.55; 95% CI: 2.87, 14.93; five studies). When subjects were matched on BMI, women with PCOS still had higher odds of both depressive (OR: 3.25; 95% CI 1.73-6.09; four studies) and anxiety symptoms (OR: 6.30, 95% CI: 1.88-21.09; three studies). There was no substantial heterogeneity among studies in the overall MA on depressive symptoms (I2 = 22.4%, P = 0.19), but there was significant heterogeneity among studies in the analysis on anxiety symptoms (I2 = 59.6%, P= 0.01). In the meta-regression evaluating pooled SMDs between groups, women with PCOS and concurrent depression had higher mean values of age, BMI, hirsutism score and IR, while women with PCOS and concurrent anxiety had higher mean values of BMI, hirsutism score and free testosterone (P < 0.05 for all comparisons). LIMITATIONS, REASON FOR CAUTION: All studies were cross-sectional, thus we can only hypothesize that the diagnosis of PCOS precedes the diagnosis of depression and anxiety. There were large variations in methodological characteristics especially in the studies screening for anxiety; however, they only partly explained effect size variation. WIDER IMPLICATIONS OF THE FINDINGS: This evidence-synthesis analysis shows that PCOS diagnosis is associated with an increased risk of moderate and severe depressive and anxiety symptoms and suggests that providers should consider screening women with PCOS for both depression and anxiety. Although age, obesity, hyperandrogenism and IR do not explain the entire association, well-designed studies are needed to assess the impact of treatment of these factors on depressive and anxiety symptoms in women with PCOS. STUDY FUNDING/COMPETING INTEREST(S): No funding was used for this study. There are no conflicts of interest. REGISTRATION NUMBER: N/A.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is concerning given the established evidence of increased depression, anxiety, eating disorders and other mental illnesses in those affected with PCOS [3, 8, 57–59].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [58]
In the citing paper
“This prevalence of eating disorders is relatively high compared to that found in other population studies that report a 0.3%-2.45% prevalence in those with PCOS.31,126,129,130”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [129]
In the citing paper
“Another meta-analysis estimated a prevalence of 36 % for depression in PCOS [69].”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [69]
In the citing paper
“The risk of developing depression may be associated with higher BMI [70], although this association is weak.”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [70]
In the citing paper
“A recent meta-analysis of depression rates among women with PCOS resulted in a median prevalence of depression of almost 37% compared to 14% in controls [8].”
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Depression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016) · Human Reproduction · doi:10.1093/humrep/dew218 · Cited by 1,526
Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement
Siu, A. L., and the US Preventive Services Task Force (USPSTF), Bibbins-Domingo, K., Grossman, D. C., Baumann, L. C., Davidson, K. W., Ebell, M., García, F. A. R., Gillman, M., Herzstein, J., et al. (2016) · JAMA · doi:10.1001/jama.2015.18392 · Cited by 1,407
Research works printed but not linked: 3
- 2014, Body image, self-esteem and depressive symptomatology in women with polycystic ovary syndrome, Noropsikiyatri Arsivi, 51, 129
- 2013, Psychiatric symptoms in women with polycystic ovary syndrome, Dusunen Adam, 26, 157
- 1992, Polycystic ovary syndrome, 377
Cited by
Items 301–400 of 750
Standeven, L. R., Hannan, K., Singh, B., & Hantsoo, L. V. (2023) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2023.03.014 · Cited by 9
Shah, R. D. (2019) · Children · doi:10.3390/children6080089 · Cited by 9
Gaps and opportunities in polycystic ovary syndrome care—a qualitative study
Zhang, A. Z., Sehrt, M. N., Ley, S. A., Ross, K. V., Phimphasone‐Brady, P., & McKenney, K. M. (2025) · F&S Reports · doi:10.1016/j.xfre.2025.05.011 · Cited by 8
Ramamurthy, K., Gopi, S., Madesh, S., Aswinanand, B., Negi, P., Selvaraj, J., Almutairi, M. H., Almutairi, B. O., Namasivayam, S. K. R., Kumaradoss, K. M., et al. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108610 · Cited by 8
Patel, P. B. K., Raval, A. M., Patel, H. B., Patel, K. H., Kumar, P. P. D., Vaidya, P. A. K., & Kahar, K. H. (2026) · Asian Journal of Pharmaceutical Research and Development · Cited by 8
Dilek, O., Atan, Ş. Ü., & Çelik, F. (2022) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_1728_21 · Cited by 8
Cui, X., Li, H., Huang, X., Xue, T., Wang, S., Zhu, X., & Jing, X. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.70089 · Cited by 8
The role of the fibrinolytic system in female reproductive disorders and depression
Hoirisch-Clapauch, S., & Brenner, B. (2020) · Thrombosis Update · doi:10.1016/j.tru.2020.100004 · Cited by 8
Polycystic ovary syndrome: a dermatologic approach
Lisboa, C., Azevedo, F., & Gomes, P. M. (2024) · Portuguese Journal of Dermatology and Venereology · doi:10.24875/pjdv.24000046 · Cited by 8
Ong, M. (2018) · OPUS - Open Publications of UTS Scholars (University of Technology Sydney) · Cited by 8
Dietary Factors and the Risk of Depression among Women with Polycystic Ovary Syndrome
Łagowska, K., Bajerska, J., & Pieczyńska-Zając, J. M. (2024) · Nutrients · doi:10.3390/nu16060763 · Cited by 7
Kim, A. E., Lee, I. T., Ottey, S., & Dokras, A. (2024) · F&S Reports · doi:10.1016/j.xfre.2024.05.004 · Cited by 7
Self-citationSacca, L., Lobaina, D., Knopf, E., Burgoa, S., Jimenez, S., Okwaraji, G., Etzel, M., Vardanyan, V., Tharp, M. E., Rao, M., et al. (2024) · Clinics and Practice · doi:10.3390/clinpract14050131 · Cited by 7
Liu, M., Hummitzsch, K., Bastian, N. A., Hartanti, M. D., Irving‐Rodgers, H. F., Anderson, R. A., & Rodgers, R. J. (2022) · Reproduction and Fertility · doi:10.1530/raf-22-0068 · Cited by 7
Fossey, B., McCaffery, K. J., Cvejic, E., Jansen, J., & Copp, T. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20115998 · Cited by 7
Contemporary Management of the Patient with Polycystic Ovary Syndrome
Francone, N. O., Ramirez, T., & Boots, C. E. (2023) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2023.08.003 · Cited by 7
Disordered Eating in Young Women with Polycystic Ovary Syndrome
Yüksel, S., Gencer, F. K., Alptekin, F. B., & Sağlam, N. G. U. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01435-1 · Cited by 7
Is polycystic ovary syndrome a risk factor for depression and anxiety?: a cross-sectional study
Günkaya, O. S., Tekin, A. B., Bestel, A., Arslan, O., Şahin, F., Taymur, B. D., & Tuğ, N. (2024) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20230918 · Cited by 7
Polycystic Ovary Syndrome (PCOS)
Hechtman, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00209-0 · Cited by 7
Health-Related Quality of Life in perimenopausal women with PCOS
Forslund, M., Landin‐Wilhelmsen, K., Krantz, E., Trimpou, P., Schmidt, J., Brännström, M., & Dahlgren, E. (2022) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog4902052 · Cited by 7
Hsieh, W.-C., Chen, C., Cheng, Y.-C., Yu, T., Hsu, C. Y., Ke, D.-S., Lin, C., & Hsu, C.-Y. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19053094 · Cited by 7
Mei, L. L., Abu, M. A., Chew, K. T., Ismail, A., Zainuddin, A. A., & Azurah, A. G. N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.848860 · Cited by 7
Berni, T. R., Morgan, C., Berni, E. R., & Rees, A. (2017) · Endocrine Abstracts · doi:10.1530/endoabs.50.p353 · Cited by 7
Sukhapure, M. (2019) · Otago University Research Archive (University of Otago) · Cited by 7
Combined Oral Contraceptives for Polycystic Ovary Syndrome: Pro and Contra (Review)
Мазеркина, И. А., Davydov, I. G., & Alyautdina, O. S. (2024) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2024-12-2-214-229 · Cited by 6
Askarpour, M., Hejazi, N., Jahromi, B. N., Eskandari, M. H., Famouri, M., & Bedeltavana, A. (2025) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2025.30.1.37 · Cited by 6
Anxiety in polycystic ovary syndrome – a meta-analysis
Humeniuk, E., Dybciak, P., Raczkiewicz, D., Powrózek, T., Malecka-Massalska, T. J., Andrzejczyk, A., Suski, K., & Bojar, I. (2025) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/202444 · Cited by 6
Mohammed, S., Sundaram, V., Cockburn, B. N., Motilal, S., Ottey, S., & Azziz, R. (2025) · Women s Health Reports · doi:10.1089/whr.2025.0008 · Cited by 6
Hofmann, K., Singer, S., Theis, S., Dionysopoulou, A., Schiestl, L. J., Degirmenci, Y., Hasenburg, A., Schwab, R. M., & Skala, C. (2025) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2025.2516669 · Cited by 6
Vieyra, E., Silva, C., Linares, R., Rosas, G., Espinoza, J.-A., Chaparro, A., Calderón, R., de la Peña, B., & Morales‐Ledesma, L. (2025) · Molecules · doi:10.3390/molecules30163407 · Cited by 6
Şentürk, Ş., Kağıtçı, M., Puşuroğlu, M., Avcı, U., Telatar, T. G., Çol, B. K., Kuruca, N., Delibaş, D. D., Hatırnaz, Ş., Mercantepe, F., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14197068 · Cited by 6
Bliddal, M., Wesselhoeft, R. T., Rasmussen, L., Janecka, M., Zaks, N., Petersen, L. K., Egsgaard, S., Jensen, P. B., & Munk‐Olsen, T. (2025) · Psychological Medicine · doi:10.1017/s0033291725102602 · Cited by 6
Łagowska, K., & Ptaszyńska, D. (2026) · Nutrients · doi:10.3390/nu18020307 · Cited by 6
Lifestyle management of polycystic ovary syndrome: a single-center study in Bosnia and Herzegovina
Djedjibegovíc, J., Marjanović, A., Kobilica, I., Turalić, A., Lugusić, A., & Šober, M. (2020) · AIMS Public Health · doi:10.3934/publichealth.2020041 · Cited by 6
Canpolat, A. G., Demir, Ö., Sert, M. S., Yarsan, B., Tekfidan, Z., Yaman, Ş. N., Oğuz, E., Gazal, E., Şimşek, H. H., Ensarı, T. A., et al. (2021) · Journal of Ankara University Faculty of Medicine · doi:10.4274/atfm.galenos.2021.52244 · Cited by 6
An Update on the Genetics of Polycystic Ovary Syndrome: PCOS and Genetics
Sharma, P., Jain, M., Tripathi, M. K., Sharma, M., & Halder, A. (2024) · Journal of Endocrinology & Reproduction · doi:10.18311/jer/2023/34654 · Cited by 6
Association of Gut Microbiota With Fatigue in Black Women With Polycystic Ovary Syndrome
Slack, J. E., Kosyakova, N., Pelkmans, J. L., Houser, M. C., Dunbar, S. B., Spencer, J. B., Ferranti, E. P., & Narapareddy, S. L. (2024) · Nursing Research · doi:10.1097/nnr.0000000000000788 · Cited by 6
Ismail, N., & Ismail, M. S. (2024) · International Journal Of Scientific Advances · doi:10.51542/ijscia.v5i6.1 · Cited by 6
Kozica, S. L., Teede, H. J., & Garad, R. M. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1667308 · Cited by 6
Epigenetic and transgenerational transmission of polycystic ovary syndrome
Stener‐Victorin, E. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.03.005 · Cited by 6
Modern aspects of management of patients with polycystic ovary syndrome
Авраменко, Н. В., Кабаченко, О. В., Барковський, Д. Є., & Sierykh, К. (2020) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2020.6.218474 · Cited by 6
Naheed, A., Hayat, A. A., Ain, Q. U., Razzaque, B., Fatima, S., & Dar, N. R. (2021) · Journal of Rawalpindi Medical College · doi:10.37939/jrmc.v25i3.1547 · Cited by 6
Sun, J., Hu, J., Zhou, X., Li, J., Hu, K., Sun, Y. W., Cao, F., Cui, L., & Chen, Z. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.03.020 · Cited by 6
Bridging the Gap: Integrating Awareness of Polycystic Ovary Syndrome Into Mental Health Practice
Standeven, L. R., Ho, A., & Hantsoo, L. V. (2024) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20230024 · Cited by 6
Modern approaches to diagnostics of hyperandrogenism distributed forms in reproductive aged women
Бурка, О. А., & Tutchenko, T. М. (2019) · Reproductive Endocrinology · doi:10.18370/2309-4117.2019.46.39-45 · Cited by 6
Burgart, J. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000582 · Cited by 6
Niksima, S. H., Odel, N. M., Khaki, S., Gheshlagh, R. G., Fallahi, A., & Kurdi, A. B. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.03.026 · Cited by 6
Simionescu, G., Ilie, O., Ciobica, A. S., Doroftei, B., Maftei, R., Grab, D., McKenna, J., Dhunna, N., Mavroudis, I. A., & Anton, E. (2020) · Brain Sciences · doi:10.3390/brainsci10060384 · Cited by 6
Does test anxiety and gender have an impact on OSCE Performance among medical students?
Arain, F. R. (2021) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2021.94165 · Cited by 6
Dutkiewicz, J., Okręglicka, K., & Nitsch-Osuch, A. (2023) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/166585 · Cited by 5
“Areas of emotional well-being, such as anxiety and depression, as well as disordered eating, psychosexual dysfunction, and negative body image, have been proven to be strongly related to PCOS [3].”
BackgroundZhou, W., Zhang, W., Fu, Z., Tang, C., Chen, P., Huang, R., Yang, C., Chen, S., Zuo, Z., He, C., et al. (2024) · Journal of Environmental Sciences · doi:10.1016/j.jes.2024.10.009 · Cited by 5
Kim, Y., Chae, K., Kim, S., Kang, S. Y., Yoon, H., & Namkung, J. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s490673 · Cited by 5
Hartmann, L., & Roomaney, R. (2025) · South African Journal of Psychology · doi:10.1177/00812463251336567 · Cited by 5
Magnusson, B. M., Long, M. C., Larson, R. J., Maycock, L., Wood, E. H., Stratford, G., & Thacker, E. L. (2025) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2025.2541951 · Cited by 5
One-carbon metabolism and risk of PCOS: insights from Mendelian randomization
Zhao, Y., Zhang, G., Pan, J., & Huang, H. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01795-z · Cited by 5
Kim, G.-M., & Jeon, G. (2022) · Nutrients · doi:10.3390/nu14142835 · Cited by 5
Mental Health Across the Menstrual Cycle in Polycystic Ovary Syndrome: Insights and Implications
Phimphasone‐Brady, P., Ross, K. V., Zhang, A. Z., Sehrt, M. N., McKenney, K. M., & Lebin, L. G. (2024) · Current Psychiatry Reports · doi:10.1007/s11920-024-01529-w · Cited by 5
ÇEVİK, M., & Yoldemir, T. (2025) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdaf050 · Cited by 5
Endometrial Receptivity in Patients with Polycystic Ovary Syndrome
Albu, A. I., & Albu, D. N. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98624 · Cited by 5
Enhanced pup retrieval behaviour in a mouse model of polycystic ovary syndrome
Aung, Z. K., Masih, R. R., Desroziers, E., Campbell, R. E., & Brown, R. S. E. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13206 · Cited by 5
Alur-Gupta, S., Boland, M. R., Dokras, A., Haendel, M. A., Chute, C. G., Walden, A., Gersing, K. R., Misquitta, L., Gersing, K. R., Burgoon, P. W., et al. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.01.025 · Cited by 5
Self-citationTime Perspective as a Mediator of Depressive Symptoms in Patients with Polycystic Ovary Syndrome
Adamczak, A., Płotek, W., Głowińska, A., Sobol, M., Wysocka, E., Polak, G., Dymanowska-Dyjak, I., Spaczyńska, J., Adamczak, Ł., & Banaszewska, B. (2023) · Healthcare · doi:10.3390/healthcare11070993 · Cited by 5
Kolasseri, A. E., Kolasseri, A. E., Jayanthi, S., & Tamizhselvi, R. (2023) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2023.2297166 · Cited by 5
Saxena, R., Singh, P., Verma, A., & Sharma, M. S. (2021) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20214789 · Cited by 5
McGowan, M., Lim, S. S., O'Reilly, S. L., Harrison, C. L., Enticott, J., Teede, H. J., Cowan, S., & Moran, L. (2023) · Nutrients · doi:10.3390/nu15112579 · Cited by 5
A Comprehensive PCOS Research and Guideline Translation Program to Improve Practice
Ramasamy, V. A., Garad, R. M., & Boyle, J. A. (2021) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1733916 · Cited by 5
The puzzle of polycystic ovary syndrome, depression, and anxiety
Greenwood, E. A. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.07.011 · Cited by 5
Patten, R. K. (2021) · Victoria University Research Repository (Victoria University) · Cited by 5
Dietary Patterns and Metabolic and Hormonal Parameters in Women with Suspected PCOS
Kowalczyk, K., Kadłubek, S., Krużel, A., Sikora, D., Daniluk, J., & Madej, P. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082708 · Cited by 4
“Additionally, no statistically significant correlations were observed in women practicing calorie counting.”
Hu, R., Zhang, L., Zhu, J., Zhao, S., Yin, L., & Hu, J. (2025) · PeerJ · doi:10.7717/peerj.19238 · Cited by 4
Association between triglyceride glucose index and depression in polycystic ovary syndrome
Chen, G., Zhu, L., Lou, Y., Wu, Y., Wang, L., Mao, W., & Ma, J. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01927-y · Cited by 4
Yeh, C.-R., Vo, H. T., Lin, C.-Y., Au, H., Lai, C.-F., Chen, S., & Duong, T. V. (2025) · BMC Women s Health · doi:10.1186/s12905-025-04053-y · Cited by 4
Wang, G., Guan, M., Li, R., He, T., Luo, L., Hu, S., Wang, B., Liu, D., & Lei, J. (2025) · Mindfulness · doi:10.1007/s12671-025-02717-2 · Cited by 4
Talukder, A., Tithi, T. A., Rumi, M. H., & Muyeed, A. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004937 · Cited by 4
Li, S., Zhang, Y., Tang, X., Deng, M., Luo, H., & Chen, Y. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1738355 · Cited by 4
Adshead, C., Sheffield, D., Fido, D., Lagojda, L., Kyrou, I., Randeva, H. S., Williams, S., & Kite, C. (2026) · Psychology International · doi:10.3390/psycholint8010015 · Cited by 4
Górna, M., Čamarová, N., Rojková, Z., & Slebodová, P. (2025) · Women · doi:10.3390/women5030035 · Cited by 4
Liao, Z., Fan, H., Fan, H., & Chen, X. (2021) · Medicine · doi:10.1097/md.0000000000024218 · Cited by 4
Nelson, K., Shirin, S., Kalidasan, D., & Prior, J. C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0296377 · Cited by 4
Samad, M., Ek, C. J., Börchers, S., Krieger, J.-P., Stener‐Victorin, E., Skibicka, K. P., Asterholm, I. W., & Benrick, A. (2024) · Scientific Reports · doi:10.1038/s41598-023-50503-8 · Cited by 4
Síndrome de Ovario Poliquístico y Salud Mental en Adolescentes
Matte, M. R., Rio, J. P. D., Fernández, O., & King, N. C. (2024) · Andes pediatrica · doi:10.32641/andespediatr.v95i5.5229 · Cited by 4
Hofmann, K., Decrinis, C., Bitterlich, N., Bachmann, A., & Stute, P. (2025) · Journal of Migration and Health · doi:10.1016/j.jmh.2025.100313 · Cited by 4
Psychological symptoms in perimenarcheal adolescents: association with PCOS risk factors
Brink, H. V., McCormick, K. C., Lujan, M. E., Chang, J. P., Ipp, L. S., Mudrak, E. L., Alladeen, A., Lamar, H., Kim, J. Y., & Mendle, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1551958 · Cited by 4
Hirsutism is associated with increased hospitalization for mental health disorders
Kim, A. B., Cheng, B. T., & Hassan, S. (2022) · Archives of Dermatological Research · doi:10.1007/s00403-022-02477-2 · Cited by 4
New aspects in the diagnosis and treatment of polycystic ovary syndrome
Efimenko, V. V., Викторович, Х. М., Gasanova, A. M., Martirosian, N. S., Кузина, И. А., Валерьевна, Г. Е., Эдуардовна, Т. М., & Petunina, N. A. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-205 · Cited by 4
Min, M., Ruan, X., Wang, H., Cheng, J., Luo, S., Xu, Z., Li, M., & Mueck, A. O. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2089108 · Cited by 4
Research Trends of Acupuncture Therapy on Polycystic Ovary Syndrome: A Bibliometric Analysis
Wang, Y., Xia, Y., Li, R., Sun, R., & Fang, J. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1989401 · Cited by 4
Depression in Polycystic Ovary Syndrome: Focusing on Pathogenesis and Treatment
Xing, L., Xu, J., Wei, Y., Chen, Y., Zhuang, H., Tang, W., Yu, S., Zhang, J., Yin, G., Wang, R., et al. (2024) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.23021032 · Cited by 4
Cao, Y., Wang, W., Song, X., Wen, Q., Xie, J., & Zhang, D. (2024) · Genes · doi:10.3390/genes15040494 · Cited by 4
Improving care for women with polycystic ovary syndrome
Dokras, A. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.04.006 · Cited by 4
Self-citationCooney, L. G. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.10.034 · Cited by 4
Self-citationUnfeminine, Unhealthy and Unusual: Women's Characterizations of Their PCOS Bodies
Fabricius, A. (2020) · The Atrium (University of Guelph) · Cited by 4
Emanuel, R. H. K., Docherty, P. D., Lunt, H., & Campbell, R. E. (2025) · Physical and Engineering Sciences in Medicine · doi:10.1007/s13246-025-01539-9 · Cited by 3
Darand, M., Ghorbani, M., Ghadiri‐Anari, A., Arabi, V., & Hosseinzadeh, M. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03695-2 · Cited by 3
Noguchi, H., Yamamoto, Y., Arata, M., Nakamura, N., Yamanaka, E., Tamura, K., Aoki, H., Takeda, A., Minato, S., Inui, H., et al. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0348 · Cited by 3
Gadiraju, M., Kim, J. Y., Green, E. M., Uribe, A. L. M., Chang, H., Burgert, T. S., Olfert, M. D., & Brink, H. V. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1628853 · Cited by 3
Xie, M., Qing, X., Huang, H., Xie, B., & Zhang, J. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01167-9 · Cited by 3
AlMekhlafi, S. A., & Campo-Redondo, M. (2026) · PLoS ONE · doi:10.1371/journal.pone.0333908 · Cited by 3
Li, J., Wu, Q., Cong, J., Chang, H., Ma, H., Zhang, D., Wang, Y., Zhang, R., Kam, R. K. T., Ho, C. S., et al. (2026) · Reproductive Medicine and Biology · doi:10.1002/rmb2.70013 · Cited by 3
Metadata
- Authors
- Cooney, L. G., Lee, I., Sammel, M. D., & Dokras, A.
- Affiliations
- Hospital of the University of Pennsylvania (US)
- Corresponding author
- Cooney, Laura G.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-09
- Volume
- 32
- Issue
- 5
- Pages
- 1075-1091
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2592269563
- Cited by
- 631
- References
- 80
- Citations by year
- 2026: 95 · 2025: 94 · 2024: 63 · 2023: 81 · 2022: 70 · 2021: 77 · 2020: 56 · 2019: 49 · 2018: 35 · 2017: 10
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- polycystic ovary syndrome, depressive symptoms, anxiety symptoms, depression prevalence, anxiety prevalence, obesity, insulin resistance, testosterone, hirsutism, body mass index, age, women's mental health, comorbidities, Rotterdam criteria, NIH criteria, screening tool, meta-regression, standardized mean difference
- MeSH terms
- Anxiety, Depression, Female, Humans, Polycystic Ovary Syndrome, Severity of Illness Index, Comorbidity, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.